Von Mehren, R. B.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/α-interferon

R Katherine Alpaugh, Margaret von Mehren, Irma Palazzo, Michael B Atkins, Joseph A Sparano, Lynn Schuchter, Louis M Weiner, Janice P Dutcher

Journal:

Medical Oncology

Year:

1998

Language:

english

File:

PDF, 731 KB

english, 1998

52

Effective antibody therapy induces host-protective antitumor immunity that is augmented by TLR4 agonist treatment

Shangzi Wang, Igor A. Astsaturov, Catherine A. Bingham, Kenneth M. McCarthy, Margaret von Mehren, Wei Xu, R. Katherine Alpaugh, Yong Tang, Bruce A. Littlefield, Lynn D. Hawkins, Sally T. Ishizaka, Lou

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 827 KB

english, 2012

53

Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatment

J. I. Clark, R. Katherine Alpaugh, Margaret von Mehren, Josephine Schultz, Julie R. Gralow, Martin A. Cheever, David B. Ring, L. M. Weiner

Journal:

Cancer Immunology, Immunotherapy

Year:

1997

Language:

english

File:

PDF, 145 KB

english, 1997

54

Redirected cellular cytotoxicity employing bispecific antibodies and other multifunctional binding proteins

Louis M. Weiner, R. Katherine Alpaugh, Margaret von Mehren

Journal:

Cancer Immunology, Immunotherapy

Year:

1997

Language:

english

File:

PDF, 120 KB

english, 1997

55

Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors

E. Claire Dees, Jeffrey R. Infante, Roger B. Cohen, Bert H. O’Neil, Suzanne Jones, Margaret von Mehren, Hadi Danaee, Yih Lee, Jeffrey Ecsedy, Mark Manfredi, Katherine Galvin, Bradley Stringer, Hua Liu

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2011

Language:

english

File:

PDF, 328 KB

english, 2011

56

New Therapeutic strategies for soft tissue sarcomas

Margaret von Mehren

Journal:

Current Treatment Options in Oncology

Year:

2003

Language:

english

File:

PDF, 377 KB

english, 2003

57

Recent advances in the management of gastrointestinal stromal tumors

Margaret von Mehren

Journal:

Current Oncology Reports

Year:

2003

Language:

english

File:

PDF, 364 KB

english, 2003

58

Imatinib-refractory gastrointestinal stromal tumors: The clinical problem and therapeutic strategies

Margaret von Mehren

Journal:

Current Oncology Reports

Year:

2006

Language:

english

File:

PDF, 109 KB

english, 2006

59

Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro

Robinson, M K, Hodge, K M, Horak, E, Sundberg, Å L, Russeva, M, Shaller, C C, von Mehren, M, Shchaveleva, I, Simmons, H H, Marks, J D

Journal:

British Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 283 KB

english, 2008

60

Evaluation of nilotinib in advanced GIST previously treated with imatinib and sunitinib

C. Cauchi, N. Somaiah, P. F. Engstrom, S. Litwin, M. Lopez, J. Lee, M. Davey, B. Bove, M. von Mehren

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2012

Language:

english

File:

PDF, 228 KB

english, 2012

61

Microscopically Positive Margins for Primary Gastrointestinal Stromal Tumors: Analysis of Risk Factors and Tumor Recurrence

Martin D. McCarter, Cristina R. Antonescu, Karla V. Ballman, Robert G. Maki, Peter W.T. Pisters, George D. Demetri, Charles D. Blanke, Margaret von Mehren, Murray F. Brennan, Linda McCall, David M. Ot

Journal:

Journal of the American College of Surgeons

Year:

2012

Language:

english

File:

PDF, 362 KB

english, 2012

62

Colorectal cancer vaccines: What we know and what we don’t yet know

Margaret von Mehren

Journal:

Seminars in Oncology

Year:

2005

Language:

english

File:

PDF, 163 KB

english, 2005

63

Other Targetable Sarcomas

Veridiana Pires de Camargo, Matt van de Rijn, Enrique de Alava, Juan Madoz-Gúrpide, Silvana Pilotti, Margaret von Mehren, Florence Pedeutour, Robert G. Maki, Piotr Rutkowski, David M. Thomas

Journal:

Seminars in Oncology

Year:

2009

Language:

english

File:

PDF, 1.15 MB

english, 2009

64

Nilotinib: A Novel, Selective Tyrosine Kinase Inhibitor

Jean-Yves Blay, Margaret von Mehren

Journal:

Seminars in Oncology

Year:

2011

Language:

english

File:

PDF, 697 KB

english, 2011

65

Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132

Dian Wang, Qiang Zhang, Charles D. Blanke, George D. Demetri, Michael C. Heinrich, James C. Watson, John P. Hoffman, Scott Okuno, John M. Kane, Margaret von Mehren, Burton L. Eisenberg

Journal:

Annals of Surgical Oncology

Year:

2012

Language:

english

File:

PDF, 507 KB

english, 2012

66

Determinants of selective tumor targeting by single-chain Fv molecules

L.M. Weiner, J. Marks, J. Huston, R. Schierb, J. McCartney, E.J. Wolf, M. von Mehren, G.P. Adams

Journal:

Immunotechnology

Year:

1996

Language:

english

File:

PDF, 132 KB

english, 1996

67

Imatinib-Resistant GIST Metastases: Predicting Outcomes of Surgical Resection

K.T. Chen, J. Farma, M. Von Mehren, J.C. Watson

Journal:

Journal of Surgical Research

Year:

2012

Language:

english

File:

PDF, 65 KB

english, 2012

68

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

Ronald P DeMatteo, Karla V Ballman, Cristina R Antonescu, Robert G Maki, Peter WT Pisters, George D Demetri, Martin E Blackstein, Charles D Blanke, Margaret von Mehren, Murray F Brennan, Shreyaskumar

Journal:

Year:

2009

Language:

english

File:

PDF, 197 KB

english, 2009

69

1138 POSTER Neutropenia as a Biomarker of Sunitinib Efficacy in Patients (Pts) With Gastrointestinal Stromal Tumour (GIST)

F. Donskov, M. von Mehren, A. Cams, S. George, R.G. Casali, S. Li, J. Perkins, G.D. Demetri

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 42 KB

english, 2011

70

Trabectedin—a targeted chemotherapy?

Margaret von Mehren

Journal:

The Lancet Oncology

Year:

2007

Language:

english

File:

PDF, 50 KB

english, 2007

71

Monoclonal Antibody Therapy for Cancer

Mehren, Margaret von, Adams, Gregory P., Weiner, Louis M.

Journal:

Annual Review of Medicine

Year:

2003

Language:

english

File:

PDF, 307 KB

english, 2003

72

Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors

Belinsky, Martin G., Rink, Lori, Flieder, Douglas B., Jahromi, Mona S., Schiffman, Joshua D., Godwin, Andrew K., Mehren, Margaret von

Journal:

Genes, Chromosomes and Cancer

Year:

2013

Language:

english

File:

PDF, 854 KB

english, 2013

73

281 POSTER Phase I and pharmacokinetic study of MLN8054, a selective inhibitor of Aurora A kinase

E. Dees, J.R. Infante, R.B. Cohen, B. O'Neil, H. Burris, M. von Mehren, G. Gray, K. Galvin, M. Manfredi, O. Eton

Journal:

European Journal of Cancer Supplements

Year:

2008

Language:

english

File:

PDF, 64 KB

english, 2008

74

1227 A phase 1, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in patients with relapsed or refractory solid tumours

M. von Mehren, C. Britten, P. Piesolor, K. Balogh, A. Bartok, S. Harris, X. Li, J. Galluppi, J. Barton, S. Leong

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 51 KB

english, 2009

75

Cost Effectiveness of Imatinib Mesylate in the Treatment of Advanced Gastrointestinal Stromal Tumours

Dr Daniel M. Huse, Margaret von Mehren, Gregory Lenhart, Heikki Joensuu, Charles Blanke, Weiwei Feng, Stan Finkelstein, George Demetri

Journal:

Clinical Drug Investigation

Year:

2007

Language:

english

File:

PDF, 118 KB

english, 2007

76

Beyond Imatinib: Second Generation c-KIT Inhibitors for the Management of Gastrointestinal Stromal Tumors

Margaret von Mehren

Journal:

Clinical Colorectal Cancer

Year:

2006

Language:

english

File:

PDF, 130 KB

english, 2006

77

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

Demetri, George D, Reichardt, Peter, Kang, Yoon-Koo, Blay, Jean-Yves, Rutkowski, Piotr, Gelderblom, Hans, Hohenberger, Peter, Leahy, Michael, von Mehren, Margaret, Joensuu, Heikki, Badalamenti, Giusep

Journal:

Year:

2013

Language:

english

File:

PDF, 348 KB

english, 2013

78

A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors

von Mehren, Margaret, Britten, Carolyn D., Pieslor, Peter, Saville, Wayne, Vassos, Artemios, Harris, Sarah, Galluppi, Gerald R., Darif, Mohamed, Wainberg, Zev A., Cohen, Roger B., Leong, Stephen

Journal:

Investigational New Drugs

Year:

2014

Language:

english

File:

PDF, 229 KB

english, 2014

79

Gastrointestinal Stromal Tumors

Vadakara, Joseph, von Mehren, Margaret

Journal:

Hematology/Oncology Clinics of North America

Year:

2013

Language:

english

File:

PDF, 193 KB

english, 2013

80

7517 POSTER Clinical tolerability of trabectedin administered by two different schedules (weekly for 3 of 4 weeks vs q3 weeks) in patients with advanced/metastatic liposarcoma or leiomyosarcoma (L-sarcomas) progressing despite prior treatment with at least anthracycline and ifosfamide

Chawla, S., Casali, P.G., von Mehren, M., Le Cesne, A., Blay, J.Y., Lebedinsky, C., Alfaro, V., Elsayed, Y., Michiels, B., Demetri, G.D.

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 61 KB

english, 2007

81

Challenges in the treatment of angiosarcoma: a single institution experience

Singla, Smit, Papavasiliou, Pavlos, Powers, Benjamin, Gaughan, John, von Mehren, Margaret, Watson, James C., Farma, Jeffrey M.

Journal:

The American Journal of Surgery

Year:

2014

Language:

english

File:

PDF, 433 KB

english, 2014

82

9402 Efficacy and safety of trabectedin in soft tissue sarcoma (STS) are independent of patient age

Demetri, G., Blay, J.Y., Yovine, A., Judson, I., Maki, R., Schuetze, S., von Mehren, M., Chawla, S., Lebedinsky, C., Le Cesne, A.

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 70 KB

english, 2009

83

7506 ORAL Up to 6 years follow-up of patients receiving imatinib mesylate (Glivec) to treat unresectable or metastatic gastrointestinal stromal tumors (GISTs)

Joensuu, H., Demetri, G.D., Heinrich, M.C., Eisenberg, B.L., Fletcher, J.A., Corless, C.L., Fletcher, C.D., Blanke, C., Heintz, D., von Mehren, M.

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 60 KB

english, 2007

84

7512 POSTER Assessing the clinical impact of trabectedin in patients with leiomyosarcomas or liposarcomas (L-sarcomas) progressing despite prior conventional chemotherapy: clinical benefit rate, growth modulation index and tumor variation as parameters of treatment effect in a randomised international trial of two trabectedin dosing regimens

Le Cesne, A., von Mehren, M., Chawla, S., Blay, J.Y., Schuetze, S., Nieto, A., Gomez, J., Santabarbara, P., Izquierdo, M.A., Demetri, G.D.

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 82 KB

english, 2007

85

[The Politics of Judicial Development in Indonesia]: Comment

Arthur Taylor von Mehren

Journal:

Comparative Studies in Society and History

Year:

1965

Language:

english

File:

PDF, 117 KB

english, 1965

86

Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial

Corless, C. L., Ballman, K. V., Antonescu, C. R., Kolesnikova, V., Maki, R. G., Pisters, P. W. T., Blackstein, M. E., Blanke, C. D., Demetri, G. D., Heinrich, M. C., von Mehren, M., Patel, S., McCarte

Journal:

Journal of Clinical Oncology

Year:

2014

Language:

english

File:

PDF, 180 KB

english, 2014

87

1979 Survey of Books Relating to the Law || A Significant Contribution to the Literature of Comparative Law

Review by: Arthur T. von Mehren

Journal:

Michigan Law Review

Year:

1979

Language:

english

File:

PDF, 117 KB

english, 1979

88

INTRODUCTION

ARTHUR T. von MEHREN and KURT H. NADELMANN

Journal:

Family Law Quarterly

Year:

1971

Language:

english

File:

PDF, 543 KB

english, 1971

89

Securities Regulation || The Proxy Rules: A Case Study in the Administrative Process

Robert B. von Mehren and John C. McCarroll

Journal:

Law and Contemporary Problems

Year:

1964

Language:

english

File:

PDF, 3.25 MB

english, 1964

90

Contemporary Perspectives in Conflict of Laws: Essays in Honor of David F. Cavers || Choice of Law and the Problem of Justice

Arthur Taylor von Mehren

Journal:

Law and Contemporary Problems

Year:

1977

Language:

english

File:

PDF, 349 KB

english, 1977

91

Contemporary Perspectives in Conflict of Laws: Essays in Honor of David F. Cavers || A Greeting to David F. Cavers

Arthur T. von Mehren, Kurt H. Nadelmann and Donald T. Trautman

Journal:

Law and Contemporary Problems

Year:

1977

Language:

english

File:

PDF, 90 KB

english, 1977

92

Le Droit Français de l'Arbitrageby Matthieu de Boisséson; Michel de Juglart

Review by: Arthur T. von Mehren

Journal:

The Cambridge Law Journal

Year:

1984

Language:

english

File:

PDF, 287 KB

english, 1984

93

International Legal Developments in Review: 2004 || Transnational Legal Practice Developments

Robert E. Lutz, Philip T. Von Mehren, Laurel S. Terry, Peter Ehrenhaft, Carole Silver, Clifford J. Hendel, Jonathan Goldsmith and Masahiro Shimojo

Journal:

The International Lawyer

Year:

2005

Language:

english

File:

PDF, 1.67 MB

english, 2005

94

SYMPOSIUM: THE UNITED STATES, THE DOHA ROUND AND THE WTO—WHERE DO WE GO FROM HERE? || Transnational Legal Practice: Cross-Border Legal Services: 2002 Year-in-Review

Robert E. Lutz, Philip T. von Mehren, Laurel S. Terry, Peter Ehrenhaft and Carole Silver

Journal:

The International Lawyer

Year:

2003

Language:

english

File:

PDF, 907 KB

english, 2003

95

INTERNATIONAL ARBITRAL TRIBUNAL: AWARD ON THE MERITS IN DISPUTE BETWEEN TEXACO OVERSEAS PETROLEUM COMPANY/CALIFORNIA ASIATIC OIL COMPANY AND THE GOVERNMENT OF THE LIBYAN ARAB REPUBLIC (Compensation for Nationalized Property)

Robert B. von Mehren

Journal:

International Legal Materials

Year:

1978

Language:

english

File:

PDF, 6.44 MB

english, 1978

96

New Therapeutic Approaches for Advanced Gastrointestinal Stromal Tumors

Somaiah, Neeta, von Mehren, Margaret

Journal:

Hematology/Oncology Clinics of North America

Year:

2009

Language:

english

File:

PDF, 134 KB

english, 2009

97

Gastrointestinal Stromal Tumors

von Mehren, Margaret, Watson, James C.

Journal:

Hematology/Oncology Clinics of North America

Year:

2005

Language:

english

File:

PDF, 269 KB

english, 2005

98

An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas

Agulnik, M., Yarber, J. L., Okuno, S. H., von Mehren, M., Jovanovic, B. D., Brockstein, B. E., Evens, A. M., Benjamin, R. S.

Journal:

Annals of Oncology

Year:

2013

Language:

english

File:

PDF, 141 KB

english, 2013

99

Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing KIT

Blanke, C. D., Demetri, G. D., von Mehren, M., Heinrich, M. C., Eisenberg, B., Fletcher, J. A., Corless, C. L., Fletcher, C. D.M., Roberts, P. J., Heinz, D., Wehre, E., Nikolova, Z., Joensuu, H.

Journal:

Journal of Clinical Oncology

Year:

2008

Language:

english

File:

PDF, 157 KB

english, 2008

100

Gastrointestinal Stromal Tumors: A Paradigm for Molecularly Targeted Therapy

von Mehren, Margaret

Journal:

Cancer Investigation

Year:

2003

Language:

english

File:

PDF, 201 KB

english, 2003